• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Vedolizumab
    |
    Weekly News Recap #Phispers Vedolizumab
    US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

    US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

    Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

    Impressions : 2004

    ImmunityBio bags maiden FDA nod for bladder cancer; Ipsen, Skyhawk partner to develop neurological therapies

    ImmunityBio bags maiden FDA nod for bladder cancer; Ipsen, Skyhawk partner to develop neurological therapies

    This week’s Phispers comes packed with news about drug approvals by the US Food and Drug Administration (FDA). The agency...

    Impressions : 1230

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.